--- title: Buy Abiraterone 250mg Pills Online description: Abiraterone 250mg pills are used in prostate cancer treatment to lower androgen levels. Available at our secure online pharmacy with verified quality and prompt delivery. type: product language: en url: https://medsforsale.net/buy-abiraterone-online-en availability: in_stock price_min: 457.99 price_max: 887.99 currency: USD offers: - name: 250mg x 120 pills price: 457.99 - name: 250mg x 240 pills price: 887.99 --- # Buy Abiraterone 250mg Pills Online Abiraterone is an androgen biosynthesis inhibitor taken as pills. It works by reducing androgen production in the body, which helps slow the progression of metastatic castration-resistant prostate cancer. This medication is for adults with this specific type of advanced prostate cancer. Order Abiraterone 250mg pills through our trusted online pharmacy. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **250mg** | 120 pills | **$457.99** | $3.82 | In Stock | | **250mg** | 240 pills | **$887.99** | $3.70 | In Stock | [Buy Now](https://medsforsale.net/buy-abiraterone-online-en) ## Introduction Abiraterone is an oral steroid-synthesis inhibitor used principally to treat advanced prostate cancer. The medication is supplied as a 250 mg tablet and belongs to the class of androgen biosynthesis inhibitors. It is approved for metastatic castration-resistant prostate cancer (mCRPC) and for metastatic hormone-sensitive prostate cancer (mHSPC) when combined with androgen-deprivation therapy. In addition to its primary indication, clinical research has explored its role in other hormone-driven malignancies, although such uses remain off-label. The drug is manufactured by multiple licensed producers; the generic formulation contains the single active compound abiraterone acetate. ## What is Abiraterone? Abiraterone is the generic version of well-known medications, containing the active compound abiraterone acetate. [our online pharmacy](https://medsforsale.net/buy-abiraterone-online-en) provides this generic alternative as a cost-effective treatment option. The molecule was originally developed by the pharmaceutical company Janssen-Cilag (part of Johnson & Johnson) and received its first regulatory approval in the United States in 2011 under the brand name **Zytiga**. In several regions the same compound is marketed under other brand names such as **Yonsa** for specific indications. The generic version is identical in chemical composition, dosage strength (250 mg) and therapeutic effect, but it is typically offered at a price close to the manufacturing cost. ## How Abiraterone Works Abiraterone acetate is a selective, irreversible inhibitor of the enzyme cytochrome P450 17A1 (CYP17A1). CYP17A1 catalyzes two critical steps in androgen biosynthesis: 17α-hydroxylation and 17,20-lyase activity. By blocking these reactions, abiraterone markedly reduces the production of testosterone and other adrenal androgens that can stimulate prostate-cancer cells even after testicular androgen suppression. The drug is a pro-drug; after oral ingestion, hepatic esterases convert it to abiraterone, which then binds to the heme-containing active site of CYP17A1. Inhibition is essentially complete within a few hours, and steady-state plasma concentrations are achieved after about 7 days of daily dosing. Because CYP17A1 is also involved in cortisol synthesis, the suppression of mineralocorticoid precursors can cause a secondary excess of aldosterone-type hormones. Consequently, abiraterone is co-administered with low-dose prednisone (or prednisolone) to restore glucocorticoid feedback and mitigate mineralocorticoid-related side effects such as hypertension, hypokalemia, and fluid retention. ## Conditions Treated with Abiraterone - **Metastatic Castration-Resistant Prostate Cancer (mCRPC).** In men whose disease progresses despite surgical or medical castration, abiraterone plus prednisone improves overall survival, delays radiographic progression, and reduces pain. Large Phase III trials (COU-AA-301) demonstrated a median overall-survival benefit of approximately 4 months compared with placebo. - **Metastatic Hormone-Sensitive Prostate Cancer (mHSPC).** When added to androgen-deprivation therapy, abiraterone postpones the transition to castration resistance and extends survival, as shown in the LATITUDE and STAMPEDE trials. - **Adrenocortical Carcinoma (experimental).** Although not approved, early-phase studies have examined abiraterone for steroid-producing adrenal tumours, reflecting its effect on adrenal androgen synthesis. These approvals are based on robust randomized clinical data, regulatory review by the FDA, EMA, and other health authorities, and a favorable risk-benefit profile when used with concurrent glucocorticoids. ## Off-Label and Investigational Uses of Abiraterone - **Androgen-Receptor Positive Breast Cancer.** Small cohort studies have reported disease stabilization when abiraterone was combined with standard endocrine therapy in women whose tumours express the androgen receptor. The evidence remains preliminary, and the approach is not approved by regulatory agencies. - **Hormone-Sensitive Ovarian Cancer (rare).** Case series have described the use of abiraterone to suppress residual androgen production in refractory ovarian carcinoma, but data are limited to anecdotal reports. - **Castration-Resistant Prostate Cancer Prior to Chemotherapy.** Some oncologists employ abiraterone earlier in the treatment sequence before docetaxel, based on retrospective analyses suggesting comparable progression-free intervals. This strategy has not yet received formal endorsement. All off-label applications should only be pursued under the direct supervision of a qualified healthcare professional, with informed consent and careful monitoring. ## Is Abiraterone the Right Medication for You? Abiraterone is indicated for adult men with advanced prostate cancer who are already receiving continuous medical or surgical castration. It is especially suitable for patients who: - Have documented metastatic disease (bone, lymph node, or visceral). - Require a systemic therapy that can be taken orally, avoiding frequent intravenous infusions. - Have preserved liver function (Child-Pugh A or B) and no contraindicating cardiac conditions. The drug is **not appropriate** for: - Women, unless enrolled in a clinical trial for a specific off-label indication. - Pregnant or breastfeeding individuals (teratogenic risk). - Patients with severe hepatic impairment (Child-Pugh C) or uncontrolled hypertension. - Individuals taking strong CYP3A4 inducers (e.g., rifampin, carbamazepine) without dose adjustment, as these agents can reduce abiraterone exposure. A thorough medical evaluation, including baseline liver-function tests, electrolyte panels, and blood pressure measurement, is required before initiating therapy. ## Risks, Side Effects, and Interactions ### Common - **Fluid retention and edema.** Often associated with mineralocorticoid excess; generally managed with low-dose prednisone and diuretics if needed. - **Hypertension.** Regular monitoring of blood pressure is recommended. - **Hypokalemia.** Serum potassium should be checked periodically; supplementation may be required. - **Fatigue and arthralgia.** Often mild to moderate in intensity. ### Rare - **Hepatotoxicity.** Elevated transaminases (ALT, AST) occur in <5 % of patients; severe cases may necessitate treatment interruption. - **Cardiac arrhythmias.** Uncommon but reported, particularly in patients with pre-existing cardiac disease. ### Serious - **Adrenal insufficiency.** If prednisone is omitted, abrupt cortisol deficiency can develop, leading to hypotension, nausea, and vomiting. Immediate medical attention is required. - **Severe hypertension or hyper-electrolytemia.** May result in cerebrovascular events if uncontrolled. #### Drug-Drug Interactions - **CYP3A4 inducers** (e.g., phenytoin, St. John’s wort) lower abiraterone plasma levels, reducing efficacy. - **CYP3A4 inhibitors** (e.g., ketoconazole, clarithromycin) can raise abiraterone concentrations, increasing toxicity risk. Dose adjustment may be necessary. - **Anticoagulants** (warfarin, direct oral anticoagulants) may have altered effect due to hepatic enzyme modulation; monitor INR or clinical signs of bleeding. - **Antihypertensives** (ACE inhibitors, ARBs) may require closer blood-pressure monitoring because of additive effects on fluid balance. #### Food and Lifestyle Interactions - Take the tablet **on an empty stomach** (at least 1 hour before or 2 hours after a meal) to ensure optimal absorption. - Avoid excessive alcohol, which can exacerbate liver injury. - Do not operate heavy machinery if you experience significant dizziness or fatigue. ## Use: Dosing, Missed Dose, Overdose - **Standard dosing:** One 250 mg tablet taken orally **once daily**, together with 5 mg of prednisone (or equivalent) taken in the morning with food to reduce gastrointestinal irritation. - **Missed dose:** If you forget a dose, take it as soon as you remember **provided it is more than 12 hours** before the next scheduled dose. If the next dose is imminent, skip the missed tablet and resume the regular schedule. Do not double-dose. - **Overdose:** Symptoms may include severe hypertension, hypokalemia, and hepatic dysfunction. Seek urgent medical care; supportive measures such as intravenous fluids, potassium replacement, and antihypertensive therapy are employed. There is no specific antidote. ### Practical Precautions - Store tablets at **room temperature**, protected from moisture and light. - Do not crush or chew the tablet; it is designed for whole-pill ingestion. - Keep out of reach of children and pets. ## FAQ - **Can I travel internationally with abiraterone?** Abiraterone tablets can be taken while traveling, but you should carry them in their original labeled container and keep a copy of the prescription or a doctor’s letter. Some countries require a medication import permit; check local regulations before departure. - **Will food affect how abiraterone works?** Yes. High-fat meals can increase the drug’s absorption and raise plasma levels, potentially increasing side-effects. The recommendation is to take the tablet on an empty stomach for consistent exposure. - **What does the tablet look like?** Generic 250 mg abiraterone tablets are typically white, round, and film-coated, bearing the imprint “AB 250” (the exact markings may vary by manufacturer). - **Are there any inactive ingredients I should be aware of?** Common excipients include microcrystalline cellulose, lactose monohydrate, magnesium stearate, and silicon dioxide. Patients with lactose intolerance should verify the formulation with the supplier. - **How long can I stay on abiraterone therapy?** Treatment continues until disease progression, unacceptable toxicity, or patient decision to discontinue. Regular imaging and laboratory monitoring guide duration. - **Does abiraterone affect hormone-based drug tests?** Yes. Because it suppresses androgen synthesis, it can lead to low testosterone levels detectable in clinical hormone panels. The drug itself is not typically screened for in standard occupational drug tests. - **Is abiraterone safe for people with mild liver disease?** It can be used in patients with Child-Pugh class A or mild B liver dysfunction, but liver enzymes must be monitored every 2-4 weeks. Severe liver impairment is a contraindication. - **Can I take abiraterone with herbal supplements?** Some herbs, such as St. John’s wort (a CYP3A4 inducer), can lower drug levels. Others, like grapefruit (a CYP3A4 inhibitor), may raise concentrations. Discuss any supplements with your healthcare provider before use. - **Will my blood pressure medication need adjustment?** Because abiraterone can cause fluid retention and raise blood pressure, clinicians often monitor blood pressure closely and may adjust antihypertensive doses during the first few weeks of therapy. - **Is a dose-splitting schedule ever used?** No. The approved regimen is a single 250 mg tablet once daily; splitting or taking multiple tablets does not provide therapeutic benefit and may increase side-effects. ## Glossary **CYP17A1 (Cytochrome P450 17A1)** : The enzyme responsible for key steps in androgen and cortisol synthesis; inhibition reduces testosterone production. **Mineralocorticoid excess** : An imbalance where aldosterone-like hormones accumulate, leading to hypertension, low potassium, and fluid retention. **Prednisone rescue** : Low-dose glucocorticoid given alongside abiraterone to replace cortisol and mitigate mineralocorticoid-related side-effects. **Child-Pugh classification** : A system used to assess the severity of chronic liver disease, ranging from class A (mild) to C (severe). ## Buying Abiraterone from [our online pharmacy](https://medsforsale.net/buy-abiraterone-online-en) Patients who encounter limited availability, high out-of-pocket costs, or insurance barriers can obtain abiraterone through **[our online pharmacy](https://medsforsale.net/buy-abiraterone-online-en)**. We source the medication exclusively from licensed, audited suppliers that meet international Good Manufacturing Practice (GMP) standards, ensuring each batch matches the potency and purity of the original brand products. - **Affordability:** By offering the generic formulation, we reduce the price to near-manufacturer cost, delivering a significant saving compared with branded alternatives. - **Verified quality:** Every shipment is accompanied by a certificate of analysis confirming the 250 mg strength and compliance with pharmacopeial specifications. - **Reliable delivery:** Orders are dispatched discreetly, with options for express shipping (approximately 7 days) or regular airmail (typically 2-3 weeks). Tracking information is provided for each parcel. - **Privacy-focused service:** As a pharmacy-broker, we partner with overseas licensed pharmacies to maintain a confidential ordering process. Packages are unbranded and sealed, safeguarding your personal information. Our platform is designed to simplify access to essential oncology medicines, offering a trustworthy conduit for patients who need abiraterone but face obstacles in traditional pharmacy channels. ## Disclaimer The information presented about **Abiraterone** is intended solely for general educational purposes and does not substitute for professional medical advice. All therapeutic decisions, including those concerning off-label applications, must be made under the direct supervision of a qualified healthcare provider. Readers are presumed to be competent adults capable of making informed health choices. [our online pharmacy](https://medsforsale.net/buy-abiraterone-online-en) provides access to **Abiraterone** for individuals who may encounter limited supply through conventional pharmacies, insurance formularies, or who seek more affordable generic options. Prior to initiating, modifying, or stopping any medication, you should always consult a qualified health professional.